plicamycin has been researched along with Metastase in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Aoki, M; Hosoda, W; Komori, K; Sakuma, K; Sasaki, E; Shimizu, Y; Yatabe, Y | 1 |
Guan, X; Jia, Z; Li, Q; Wang, L; Wei, D; Xie, K; Yao, J; Zhang, J | 1 |
Aoyama, T; Furu, M; Kajita, Y; Katagiri, T; Kato, T; Nagayama, S; Nakamura, E; Nakamura, Y; Nishiyama, H; Ogawa, O; Takahashi, R; Tamaki, S; Toguchida, J | 1 |
3 other study(ies) available for plicamycin and Metastase
Article | Year |
---|---|
MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L-like during epithelial-mesenchymal transition.
Topics: Binding Sites; Cell Proliferation; Colorectal Neoplasms; Disease Progression; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Knockout Techniques; Heterogeneous-Nuclear Ribonucleoproteins; HT29 Cells; Humans; Neoplasm Metastasis; Plicamycin; Promoter Regions, Genetic; Proto-Oncogene Proteins c-myb; Sp1 Transcription Factor; Transcription, Genetic; Transfection | 2021 |
Targeted inhibition of Sp1-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse models.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Female; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Neovascularization, Pathologic; Plicamycin; Sp1 Transcription Factor; Stomach Neoplasms; Transcription, Genetic; Vascular Endothelial Growth Factor A | 2008 |
The transcription factor Sp3 regulates the expression of a metastasis-related marker of sarcoma, actin filament-associated protein 1-like 1 (AFAP1L1).
Topics: Adaptor Proteins, Signal Transducing; Binding Sites; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Luciferases; Microfilament Proteins; Neoplasm Metastasis; Plicamycin; Promoter Regions, Genetic; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sarcoma; Sp3 Transcription Factor; Transcriptional Activation | 2013 |